A Human Proof-of-Concept Study Comparing the Pharmacokinetics of Novel Inhaled Dronabinol with the Oral Dronabinol
Phase of Trial: Phase I
Latest Information Update: 28 Sep 2018
Price : $35 *
At a glance
- Drugs Dronabinol (Primary) ; Dronabinol
- Indications Anorexia; Chemotherapy-induced nausea and vomiting
- Focus Pharmacokinetics; Proof of concept; Registrational
- Sponsors INSYS Therapeutics, Inc
- 28 Sep 2018 New trial record
- 24 Sep 2018 Results presented in a Senzer Limited media release.
- 24 Sep 2018 Results presented in an INSYS Therapeutics media release.